Search clinical trials for: HER2 x CD3 bispecific antibody
Total 37153 results
-
Novartis PharmaceuticalsBreast International Group; German Breast Group; SOLTI Breast Cancer Research...CompletedHER2-positive Newly Diagnosed, Primary Breast CancerAustria, Spain, Australia, Germany
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...CompletedGlioblastoma Multiforme (GBM)United States
-
Puma Biotechnology, Inc.CompletedAdvanced Breast CancerUnited States, Switzerland, China, France
-
H. Kim LyerlySusan G. Komen Breast Cancer FoundationCompleted
-
Gangnam Severance HospitalSamsung Medical Center; Asan Medical Center; Seoul National University Hospital; Severance HospitalUnknownBreast CancerKorea, Republic of
-
Roswell Park Cancer InstituteAstraZeneca; National Center for Complementary and Integrative Health (NCCIH)Completed
-
Consorzio OncotechClinical Research Technology S.r.l.UnknownMetastatic Breast CancerItaly
-
Tongji UniversityUnknownNon-small Cell Lung CancerChina
-
Genentech, Inc.Completed
-
NYU Langone HealthWithdrawnStomach Cancer | Esophageal CancerUnited States
-
Genentech, Inc.Completed
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.CompletedRelapsed/Refractory Multiple MyelomaUnited States, France
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingMetastatic Breast CancerItaly
-
University Hospital, Basel, SwitzerlandCompletedLymphoma | Myelodysplastic Syndromes | Leukemia, Myeloid, Acute | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Neuroblastoma | RhabdomyosarcomaSwitzerland, Germany
-
Charite University, Berlin, GermanyUniversity of LeipzigUnknownAcute Myeloid Leukemias | Advanced Hematological Malignancies | Indication for Allogeneic Stem Cell Transplantation | no HLA-identical Donor AvailableGermany
-
Jules Bordet InstituteCompletedBreast Neoplasms | Secondary | HER2 Positive Carcinoma of BreastBelgium
-
Yale UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Juvenile...Completed
-
Sichuan UniversityRecruitingPleural Effusion, Malignant | Peritoneal Carcinoma MetastaticChina
-
Northwestern UniversityNational Cancer Institute (NCI); PfizerTerminatedStage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | HER2/Neu Positive | Progesterone Receptor Negative | Breast Carcinoma Metastatic in the BrainUnited States
-
Daiichi SankyoRecruitingBreast Cancer | Advanced Cancer | HER2-positive Breast Cancer | HER2-low Breast CancerChina
-
PfizerActive, not recruitingMultiple Myeloma | Refractory Multiple Myeloma | Myeloma | Relapsed Multiple Myeloma | Elranatamab | PF-06863135 | BCMA | Bispecific | Bispecific Antibody | BCMA-CD3 Bispecific | MagnetisMM-8China
-
Consorzio OncotechCompleted
-
University of WashingtonNational Cancer Institute (NCI); National Center for Complementary and Integrative...CompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | HER2/Neu PositiveUnited States
-
NRG OncologyNational Cancer Institute (NCI); Alliance for Clinical Trials in Oncology; Eastern... and other collaboratorsRecruitingHER2-positive Breast CancerUnited States, Puerto Rico
-
Jazz PharmaceuticalsALX Oncology Inc.Active, not recruitingHER2-expressing CancersUnited States
-
Molecular Templates, Inc.TerminatedHER2-positive Solid CancersUnited States, Australia, New Zealand
-
Carisma Therapeutics IncRecruiting
-
Seagen Inc.CompletedTriple Negative Breast Neoplasms | Hormone Receptor Positive Breast Neoplasms | HER2 Positive Breast Neoplasms | HER2 Mutations Breast NeoplasmsUnited States
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...Active, not recruitingBrain Tumor, Recurrent | Brain Tumor, RefractoryUnited States
-
University Hospital TuebingenCompletedHematologic MalignanciesGermany
-
Second Military Medical UniversityUnknown
-
PfizerCompletedMultiple MyelomaCanada, United States
-
St. Vincent Medical Center - Los AngelesUnknownUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
ITabMed Co., Ltd.Not yet recruitingRecurrent or Metastatic Solid Tumors
-
EVIVE BiotechnologyPeking University Cancer Hospital & InstituteUnknownRelapsed or Refractory B-cell Lymphoma
-
University of WashingtonUnited States Department of DefenseRecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States
-
Ehab L AtallahRecruitingAcute Myeloid Leukemia | T Cell Lymphoblastic Lymphoma | T Cell Acute Lymphoblastic LeukemiaUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)Withdrawn
-
Yuhan CorporationRecruitingHER2-Positive Solid TumorKorea, Republic of, Australia
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | HER2 Positive Breast CarcinomaUnited States
-
Providence Health & ServicesActive, not recruitingBreast CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Genentech, Inc.; Brigham and Women's HospitalActive, not recruitingCAPOX, Bevacizumab and Trastuzumab for Patients With HER2-Positive Metastatic Esophagogastric CancerGastric Cancer | Esophageal CancerUnited States
-
Barbara Ann Karmanos Cancer InstituteCompletedColorectal Cancer | Pancreatic Cancer | Colon Carcinoma | Cancer of Pancreas | Pancreatic Neoplasm | Malignant Neoplasm of Large Intestine | Cancer of Colon | Malignant Tumor of ColonUnited States
-
Inspira Medical ABNasVax LtdUnknownChronic Hepatitis CAustria, Poland
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.RecruitingGynecological MalignanciesChina
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Germany, Italy, Spain, Sweden, Japan
-
Dana-Farber Cancer InstituteJohns Hopkins University; National Cancer Institute (NCI); Gateway for Cancer... and other collaboratorsRecruitingBreast Cancer | Metastatic Breast Cancer | HER2-positive Breast CancerUnited States
-
Seagen Inc.Array BioPharmaCompleted
-
Peking UniversityRemeGen Co., Ltd.RecruitingHER2-Positive Solid TumorsChina